Yestar Health (02393.HK) announced on August 14 that the board of directors will hold a meeting on August 29, 2024 (Thursday), to (including) consider and approve the unaudited comprehensive mid-term performance of the company and its subsidiary companies for the six months ending June 30, 2024, as well as declare a mid-term dividend (if any).
巨星医疗控股(02393.HK)拟8月29日举行董事会会议批准中期业绩
Yestar Health (02393.HK) plans to hold a board of directors meeting on August 29 to approve the mid-term performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.